Chemical PA164750594

Overview
Prescribing Info
Drug Label Annotations
Clinical Annotations
Variant Annotations
Literature
Pathways
Related To
Links
Navigate to...
Show section selector dropdown

Literature

The publications shown below are associated with this chemical in PharmGKB based on (1) literature annotations, (2) variant annotations, (3) VIP summaries, or (4) pathways.

    4 items
    Literature
    Drugs@FDA: Drug Product Ontak (denileukin difitox), BLA103767/SUPPL-5144, 02/10/2020
    2020.
    Literature
    Denileukin Diftitox (Ontak) as Maintenance Therapy for Peripheral T-Cell Lymphomas: Three Cases with Sustained Remission.
    Case reports in oncological medicine. 2015. Fuentes Alejandra C, Szwed Ellen, Spears Cathy D, Thaper Sandeep, Dang Long H and Dang Nam H.
    Literature
    Interleukin 2 (IL-2) receptor expression and sensitivity to diphteria fusion toxin DAB389IL-2 in cultured hematopoietic cells.
    Cancer research. 1996. Re G G, Waters C, Poisson L, Willingham M C, Sugamura K and Frankel A E.
    Literature
    Drugs@FDA: Drug Product denileukin diftitox (BLA103767)